The latest edition of the GIST and Sarcoma Journal is now available online. The GIST and Sarcoma Journal is a comprehensive and authoritative resource for scientifically valid information for physicians, allied healthcare professionals and the patient community regarding advances in the diagnosis and treatment of gastrointestinal stromal tumors and other sarcomas. In the latest issue, […]
Dr. Jonathan Trent, GIST and Sarcoma Journal, GIST Education, GIST research, liquid biopsy, National Leiomyosarcoma Foundation, New York Presbyterian/Columbia University Medical Center, SarcomaA significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, a follow-up of a randomized clinical trial of 695 adult GIST patients, was coordinated by SWOG, with participation from member and […]
Clinical Trial, Dr. Michael Heinrich, GIST research, Gleevec, imatinib, JAMA Oncology, KIT exon 11, research, SWOG
The Life Raft Group presented an informative webcast on Gene Fusions. Presented on February 22, 2017 Learn about: Recently identified gene fusions in GIST Populations they target Current studies that may identify them How they can be used to guide therapeutic decision making. About the presenter Dr. Sicklick is the Associate Professor of Surgery at Moores Cancer […]
Recent findings from a population-based retrospective cohort study at the at Moores Cancer Center at UC San Diego Health, led by senior author, Jason Sicklick, MD, indicate that small intestine tumors in adolescents and young adults with Gastrointestinal Stromal Tumor (GIST) were associated with improved survival when compared to stomach tumors. This is a surprising […]
Adolescent and Young Adult GIST patients, Dr. Jason Sicklick, GIST, Moores Cancer Center, overall survival, Surgical Management